News
ENOV
27.92
+3.37%
0.91
This Spire Global Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
Benzinga · 11h ago
4 Analysts Assess Enovis: What You Need To Know
Benzinga · 12h ago
Enovis Price Target Announced at $41.00/Share by BTIG
Dow Jones · 13h ago
BTIG Initiates Coverage On Enovis with Buy Rating, Announces Price Target of $41
Benzinga · 13h ago
Enovis initiated with a Buy at BTIG
TipRanks · 13h ago
Enovis Appoints Oliver Engert as Chief Administrative Officer
Barchart · 1d ago
Enovis price target lowered to $40 from $44 at Evercore ISI
TipRanks · 1d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Enovis (ENOV) and Icon (ICLR)
TipRanks · 1d ago
Weekly Report: what happened at ENOV last week (1229-0102)?
Weekly Report · 1d ago
3 Unprofitable Stocks That Concern Us
Barchart · 1d ago
Weekly Report: what happened at ENOV last week (1222-1226)?
Weekly Report · 12/29/2025 10:23
Weekly Report: what happened at ENOV last week (1215-1219)?
Weekly Report · 12/22/2025 10:23
Is Enovis’ Extended Debt Maturities And HR Succession Plan Altering The Investment Case For ENOV?
Simply Wall St · 12/18/2025 12:16
Enovis Price Target Cut to $50.00/Share From $58.00 by Canaccord Genuity
Dow Jones · 12/17/2025 20:24
Enovis Is Maintained at Buy by Canaccord Genuity
Dow Jones · 12/17/2025 20:24
Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $50
Benzinga · 12/17/2025 20:14
Why Enovis (ENOV) Stock Is Trading Up Today
Barchart · 12/17/2025 12:56
Enovis price target lowered to $50 from $58 at Canaccord
TipRanks · 12/17/2025 12:25
Enovis (ENOV) Gets a Buy from Canaccord Genuity
TipRanks · 12/17/2025 12:08
Enovis Initiated at Buy by Freedom Capital Markets
Dow Jones · 12/17/2025 09:29
More
Webull provides a variety of real-time ENOV stock news. You can receive the latest news about Enovis Corp through multiple platforms. This information may help you make smarter investment decisions.
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).